Processa Pharmaceuticals, Inc. Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net
Processa Pharmaceuticals, Inc. (PCSA) had Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net of $2.79 thousand as of 2014-12-31, per its 10-K filed 2017-06-19.
Discontinued › Balance Sheet › Assets › Assets, Current › Disposal Group, Including Discontinued Operation, Assets, Current
us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet · last filed 2017-06-19
- 2014-12-31: Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net $2.79K.
| Period end | Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net |
|---|---|
| 2014-12-31 | $2.79K 10-K · filed 2017-06-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |